| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 10/26/2004 | US6808914 Nucleotide sequences coding polypeptide for use in the biosynthesis of amino acid for use in human medicine and animal nutrients |
| 10/26/2004 | US6808913 Comprises genetically engineered subtilisin for improved washing abilty of deteregents |
| 10/26/2004 | US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis |
| 10/26/2004 | US6808911 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/26/2004 | US6808910 Preferential lyase for use in the generation of biodegradable products |
| 10/26/2004 | US6808909 Thermostable phytase with 2.1 Å . . . crystal structure |
| 10/26/2004 | US6808905 Lentiviral vectors encoding clotting factors for gene therapy |
| 10/26/2004 | US6808904 Herbicide-tolerant protox genes produced by DNA shuffling |
| 10/26/2004 | US6808896 Generation of a genetically engineered cell; obtain cell, incubate with expression vector, transform, propagate cells, express vector, recover cell expressing reporter molecule |
| 10/26/2004 | US6808895 DNA encoding oxidoreductase and polypeptide encoded thereby |
| 10/26/2004 | US6808892 Inositolphosphoryl-ceramide (ipc) synthase; antifungal targets; drug screening; genetic engineering |
| 10/26/2004 | US6808891 Modulators of the function of FAS/APO1 receptors |
| 10/26/2004 | US6808883 Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probes |
| 10/26/2004 | US6808882 Isolating preferential nucleotide sequences; obtain nucleotide sequence samples, encapsulate into microcapsules, monitor gene expression activities |
| 10/26/2004 | US6808880 Method for detecting polynucleotides encoding telomerase |
| 10/26/2004 | US6808878 Genes from the 20Q13 amplicon and their uses |
| 10/26/2004 | US6808708 Compositions and methods relating to reduction of symptoms of autism |
| 10/26/2004 | CA2301818C Bifunctional compounds useful in catalyst reporter deposition |
| 10/26/2004 | CA2261999C Invertase inhibitor |
| 10/26/2004 | CA2137237C Purified forms of dnase |
| 10/26/2004 | CA2131161C Production of aspergillus niger catalase-r |
| 10/21/2004 | WO2004091150A2 Cyp2s1 as target dor diagnosis and therapy of skin diseases |
| 10/21/2004 | WO2004090553A1 Thyroid hormone analysis by mass spectrometry |
| 10/21/2004 | WO2004090162A1 Screening methods and sequences relating thereto |
| 10/21/2004 | WO2004090158A1 Drug |
| 10/21/2004 | WO2004090155A2 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 10/21/2004 | WO2004090146A1 Delivery of nucleic acids into eukaryotic genomes using in vitro assembled mu transposition complexes |
| 10/21/2004 | WO2004090143A2 Modulation of cytokinin activity in plants |
| 10/21/2004 | WO2004090140A2 Methods and means for increasing the tolerance of plants to stress conditions |
| 10/21/2004 | WO2004090138A1 Method for the production of vitamin b12 |
| 10/21/2004 | WO2004090137A1 Novel gene |
| 10/21/2004 | WO2004090136A1 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue |
| 10/21/2004 | WO2004090133A2 Method of rna cleavage and recombination |
| 10/21/2004 | WO2004090127A1 Agar-digesting enzyme and utilization thereof |
| 10/21/2004 | WO2004090126A2 Phosphodiesterase 10a7 isoforms and methods of use |
| 10/21/2004 | WO2004090124A2 Sequences encoding s-hydroxynitril lyases and their use in methods for the production of cyanohydrins |
| 10/21/2004 | WO2004090123A2 Δ-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 10/21/2004 | WO2004090114A2 Compositions and methods of using a synthetic dnase i |
| 10/21/2004 | WO2004090106A2 Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design |
| 10/21/2004 | WO2004090101A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | WO2004090099A2 Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | WO2004090098A2 Phosphatase regulation of nucleic acid transcription |
| 10/21/2004 | WO2004090094A2 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 10/21/2004 | WO2004089393A1 Photoaging inhibitor, photoaging-improving agent, collagenase inhibitor and tyrosinase inhibitor |
| 10/21/2004 | WO2004089305A2 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 10/21/2004 | WO2004089285A2 Phosphodiesterase 2a and methods of use |
| 10/21/2004 | WO2004089097A1 Composition with heart rate reducing properties |
| 10/21/2004 | WO2004089066A1 Manipulation of organic acid biosynthesis and secretion |
| 10/21/2004 | WO2004081185A3 Methods to enhance the activity of lignocellulose-degrading enzymes |
| 10/21/2004 | WO2004078912A3 Chicken rna polymerase i promoter and the use thereof |
| 10/21/2004 | WO2004072305A3 Atlastin |
| 10/21/2004 | WO2004044173A3 Cis-prenyltransferases from the rubber-producing plants russian dandelion (taraxacum kok-saghyz) and sunflower (helianthus annus) |
| 10/21/2004 | WO2004037004A3 Encapsulated functional bakery ingredients |
| 10/21/2004 | WO2004035733A3 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
| 10/21/2004 | WO2004022764A3 Use of malate dehydrogenase for nadh regeneration |
| 10/21/2004 | WO2004018385A3 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
| 10/21/2004 | WO2004016223A3 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 10/21/2004 | WO2004009032A3 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 10/21/2004 | WO2003091835A3 Computationally targeted evolutionary design |
| 10/21/2004 | WO2003076576A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/21/2004 | WO2003072726A3 Nad phosphite oxidoreductase a novel catalyst from bacteria for regeneration of nad(p)h |
| 10/21/2004 | WO2003068909A3 Transaminases, nucleic acids encoding them and methods of making and using them |
| 10/21/2004 | WO2003060081A3 Compositions and methods relating to endometrial specific genes and proteins |
| 10/21/2004 | WO1995027066A9 Dna encoding ubiquitin conjugating enzymes |
| 10/21/2004 | US20040210953 Lysozyme transgenic ungulates |
| 10/21/2004 | US20040209800 Use of mx gtpases in the prognosis and treatment of cancer |
| 10/21/2004 | US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis |
| 10/21/2004 | US20040209356 incubating isomaltulose with sorbitol dehydrogenase; host cells |
| 10/21/2004 | US20040209345 cyanide resistant; cultured from rhodococcus; for producing 2-hydroxy-4-methylthiobutyroamide from hydroxy nitrile compounds |
| 10/21/2004 | US20040209344 Crystal structure of angiotensin-converting enzyme-related carboxypeptidase |
| 10/21/2004 | US20040209343 Novel subtilases |
| 10/21/2004 | US20040209342 Comprises nucleotide sequences coding hydrolase for use in identifying modulators for treatment of diabetes and inflammatory diseases |
| 10/21/2004 | US20040209341 Plant amino acid biosynthetic enzymes |
| 10/21/2004 | US20040209340 Enzymatic degradation chains |
| 10/21/2004 | US20040209327 Regulation of human transmembrane serine protease |
| 10/21/2004 | US20040209325 Comprises expression vectors coding nucleotide sequences for transformation and generation of plants with enhanced freeze, disease, drought and salt resistance |
| 10/21/2004 | US20040209317 Methods and compositions for peptide and protein labeling |
| 10/21/2004 | US20040209302 Destabilized bioluminescent proteins |
| 10/21/2004 | US20040209297 Novel human kinases and polynucleotides encoding the same |
| 10/21/2004 | US20040209277 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation |
| 10/21/2004 | US20040209276 Heat resistant polymerases for use in propagation and replication of nucleic acids |
| 10/21/2004 | US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders |
| 10/21/2004 | US20040209257 Method for cloning and expression of AcuI restriction endonuclease and AcuI methylase in E. coli |
| 10/21/2004 | US20040209256 Transforming microorganisms with expression vector comprising hydrogenase sequences for use in generating hydrogen producing microbes |
| 10/21/2004 | US20040208786 Autologous coagulant produced from anticoagulated whole blood |
| 10/21/2004 | US20040205910 supplying hair dyes, melanin, proteins, nucleic acids; encapsulated in liposomes |
| 10/21/2004 | DE10315760A1 L-Carnitin Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von substituierten (S)-Alkanolen L-carnitine dehydrogenases, their derivatives and to a process for the preparation of substituted (S) -alkanols |
| 10/21/2004 | DE10313972A1 Gekoppeltes cofaktorabhängiges enzymatisches Reaktionssystem Cofaktorabhängiges coupled enzymatic reaction system |
| 10/21/2004 | DE10313971A1 Gekoppeltes cofaktorabhängiges enzymatisches Reaktionssystem Cofaktorabhängiges coupled enzymatic reaction system |
| 10/21/2004 | CA2522056A1 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue |
| 10/21/2004 | CA2521729A1 Methods and means for increasing the tolerance of plants to stress conditions |
| 10/21/2004 | CA2521631A1 Composition with heart rate reducing properties |
| 10/21/2004 | CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 10/21/2004 | CA2521378A1 .delta.-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 10/21/2004 | CA2521288A1 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
| 10/21/2004 | CA2521169A1 Pharmaceutical agents |
| 10/21/2004 | CA2520866A1 Phosphodiesterase 2a and methods of use |
| 10/21/2004 | CA2520803A1 Phosphodiesterase 10a7 isoforms and methods of use |
| 10/21/2004 | CA2519626A1 Thyroid hormone analysis by mass spectrometry with minimal sample preparation |
| 10/20/2004 | EP1469316A1 Screening method |